Bioxytran, Inc.
BIXT
$0.1567
-$0.0054-3.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.37M | -2.89M | -3.70M | -4.49M | -4.47M |
| Total Depreciation and Amortization | 7.90K | 8.80K | 9.10K | 9.80K | 8.30K |
| Total Amortization of Deferred Charges | 677.80K | 55.00K | 30.00K | 348.60K | 348.60K |
| Total Other Non-Cash Items | 399.10K | 354.10K | 663.40K | 608.60K | 138.80K |
| Change in Net Operating Assets | 1.23M | 2.28M | 2.43M | 2.86M | 3.20M |
| Cash from Operations | -55.80K | -192.50K | -565.30K | -664.10K | -775.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.30K | -22.80K | -26.40K | -45.60K | -44.30K |
| Cash from Investing | -28.30K | -22.80K | -26.40K | -45.60K | -44.30K |
| Total Debt Issued | 0.00 | 61.50K | 61.50K | 61.50K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 63.00K | 108.00K | 498.40K | 554.40K | 550.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -50.00K | 0.00 |
| Cash from Financing | 63.00K | 169.50K | 559.90K | 565.90K | 550.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.90K | -45.60K | -31.70K | -143.80K | -269.30K |